All
Media
13
December
2024

Maddyness: An interview with our CEO Sam Windsor

Our CEO Sam Windsor was interviewed by Maddyness as part of their quick founder questions series. 

He explains how Ignota Labs approach to drug development is different. Drug safety failures account for 56% of all failed compounds, costing the pharmaceutical industry over $400B. When the failures happen, the understanding of what actually went wrong is poor to non-existent. Our platform not only gets to a granular, molecular, and biological cause of the safety problem, but it also answers a very key commercial question: if you give us 1,000 failed drugs, we can find the 10%-20% that are genuinely salvageable and can be turned around. 

Read more:
Ignota Labs, solving drug safety issues and bringing new hope to patients’ can be read in full at Maddyness.

Published: 13 December 2024 by Maddyness

Contact Us

The Bradfield Centre, 184
Cambridge Science Park Rd,
Milton, Cambridge CB4 0GA
img